- call +1-201-465-4211
- email sales@marketsandresearch.biz
- Call +1-201-465-4211
- Email: sales@marketsandresearch.biz
A CDMO is a contract development and manufacturing organization, meaning they not only handle the outsourced manufacturing of drug substances, but also all of the innovation and development work that occurs prior to manufacturing one. This includes development, production and analysis, and pharmaceutical companies no longer need to build and staff dedicated innovation and manufacturing facilities.
According to our latest study, the global Pharmaceutical Contract Development and Manufacturing Organization market size was valued at USD million in 2022 and is forecast to a readjusted size of USD million by 2029 with a CAGR of % during review period. The influence of COVID-19 and the Russia-Ukraine War were considered while estimating market sizes.
This report is a detailed and comprehensive analysis for global Pharmaceutical Contract Development and Manufacturing Organization market. Both quantitative and qualitative analyses are presented by company, by region & country, by Type and by Application. As the market is constantly changing, this report explores the competition, supply and demand trends, as well as key factors that contribute to its changing demands across many markets. Company profiles and product examples of selected competitors, along with market share estimates of some of the selected leaders for the year 2023, are provided.
Key Features:
Global Pharmaceutical Contract Development and Manufacturing Organization market size and forecasts, in consumption value ($ Million), 2018-2029
Global Pharmaceutical Contract Development and Manufacturing Organization market size and forecasts by region and country, in consumption value ($ Million), 2018-2029
Global Pharmaceutical Contract Development and Manufacturing Organization market size and forecasts, by Type and by Application, in consumption value ($ Million), 2018-2029
Global Pharmaceutical Contract Development and Manufacturing Organization market shares of main players, in revenue ($ Million), 2018-2023
The Primary Objectives in This Report Are:
To determine the size of the total market opportunity of global and key countries
To assess the growth potential for Pharmaceutical Contract Development and Manufacturing Organization
To forecast future growth in each product and end-use market
To assess competitive factors affecting the marketplace
This report profiles key players in the global Pharmaceutical Contract Development and Manufacturing Organization market based on the following parameters - company overview, production, value, price, gross margin, product portfolio, geographical presence, and key developments. Key companies covered as a part of this study include Catalent, Recipharm, Jubilant Life Sciences, Patheon Inc. and Boehringer Ingelheim, etc.
This report also provides key insights about market drivers, restraints, opportunities, new product launches or approvals, COVID-19 and Russia-Ukraine War Influence.
Market segmentation
Pharmaceutical Contract Development and Manufacturing Organization market is split by Type and by Application. For the period 2018-2029, the growth among segments provide accurate calculations and forecasts for consumption value by Type and by Application. This analysis can help you expand your business by targeting qualified niche markets.
Market segment by Type
API Development
Pharmaceutical Manufacturing
Market segment by Application
Large Enterprise
SME
Market segment by players, this report covers
Catalent
Recipharm
Jubilant Life Sciences
Patheon Inc.
Boehringer Ingelheim
Pfizer Centreone
Aenova Group
Famar
Baxter Pharmaceutical Solutions
Lonza Group
Tesa Labtec
Tapemark
ARX LLC
Cambrex
Samsung Biologics
Fujifilm Diosynth Biotechnologies
WuXi Biologics
Center for Breakthrough Medicines (CBM)
Siegfried AG
Market segment by regions, regional analysis covers
North America (United States, Canada, and Mexico)
Europe (Germany, France, UK, Russia, Italy, and Rest of Europe)
Asia-Pacific (China, Japan, South Korea, India, Southeast Asia, Australia and Rest of Asia-Pacific)
South America (Brazil, Argentina and Rest of South America)
Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of Middle East & Africa)
The content of the study subjects, includes a total of 13 chapters:
Chapter 1, to describe Pharmaceutical Contract Development and Manufacturing Organization product scope, market overview, market estimation caveats and base year.
Chapter 2, to profile the top players of Pharmaceutical Contract Development and Manufacturing Organization, with revenue, gross margin and global market share of Pharmaceutical Contract Development and Manufacturing Organization from 2018 to 2023.
Chapter 3, the Pharmaceutical Contract Development and Manufacturing Organization competitive situation, revenue and global market share of top players are analyzed emphatically by landscape contrast.
Chapter 4 and 5, to segment the market size by Type and application, with consumption value and growth rate by Type, application, from 2018 to 2029.
Chapter 6, 7, 8, 9, and 10, to break the market size data at the country level, with revenue and market share for key countries in the world, from 2018 to 2023.and Pharmaceutical Contract Development and Manufacturing Organization market forecast, by regions, type and application, with consumption value, from 2024 to 2029.
Chapter 11, market dynamics, drivers, restraints, trends, Porters Five Forces analysis, and Influence of COVID-19 and Russia-Ukraine War
Chapter 12, the key raw materials and key suppliers, and industry chain of Pharmaceutical Contract Development and Manufacturing Organization.
Chapter 13, to describe Pharmaceutical Contract Development and Manufacturing Organization research findings and conclusion.
The base year for the study has been considered 2019, historic year 2014 and 2018, the forecast period considered is from 2020 to 2027. The regions analyzed for the market include North America, Europe, South America, Asia Pacific, and Middle East and Africa. These regions are further analyzed at the country-level. The study also includes attractiveness analysis of type, application and regions which are benchmarked based on their market size, growth rate and attractiveness in terms of present and future opportunity for understanding the future growth of the market.
Market is segmented on the basis:
The report offers in-depth analysis of driving factors, opportunities, restraints, and challenges for gaining the key insight of the market. The report emphasizes on all the key trends that play a vital role in the enlargement of the market from 2019 to 2026.
The report provides company profile of the key players operating in the market and a comparative analysis based on their business overviews industry offering, segment market share, regional presence, business strategies, innovations, mergers & acquisitions, recent developments, joint venture, collaborations, partnerships, SWOT analysis, and key financial information.
1 Market Overview
1.1 Product Overview and Scope of Pharmaceutical Contract Development and Manufacturing Organization
1.2 Market Estimation Caveats and Base Year
1.3 Classification of Pharmaceutical Contract Development and Manufacturing Organization by Type
1.3.1 Overview: Global Pharmaceutical Contract Development and Manufacturing Organization Market Size by Type: 2018 Versus 2022 Versus 2029
1.3.2 Global Pharmaceutical Contract Development and Manufacturing Organization Consumption Value Market Share by Type in 2022
1.3.3 API Development
1.3.4 Pharmaceutical Manufacturing
1.4 Global Pharmaceutical Contract Development and Manufacturing Organization Market by Application
1.4.1 Overview: Global Pharmaceutical Contract Development and Manufacturing Organization Market Size by Application: 2018 Versus 2022 Versus 2029
1.4.2 Large Enterprise
1.4.3 SME
1.5 Global Pharmaceutical Contract Development and Manufacturing Organization Market Size & Forecast
1.6 Global Pharmaceutical Contract Development and Manufacturing Organization Market Size and Forecast by Region
1.6.1 Global Pharmaceutical Contract Development and Manufacturing Organization Market Size by Region: 2018 VS 2022 VS 2029
1.6.2 Global Pharmaceutical Contract Development and Manufacturing Organization Market Size by Region, (2018-2029)
1.6.3 North America Pharmaceutical Contract Development and Manufacturing Organization Market Size and Prospect (2018-2029)
1.6.4 Europe Pharmaceutical Contract Development and Manufacturing Organization Market Size and Prospect (2018-2029)
1.6.5 Asia-Pacific Pharmaceutical Contract Development and Manufacturing Organization Market Size and Prospect (2018-2029)
1.6.6 South America Pharmaceutical Contract Development and Manufacturing Organization Market Size and Prospect (2018-2029)
1.6.7 Middle East and Africa Pharmaceutical Contract Development and Manufacturing Organization Market Size and Prospect (2018-2029)
2 Company Profiles
2.1 Catalent
2.1.1 Catalent Details
2.1.2 Catalent Major Business
2.1.3 Catalent Pharmaceutical Contract Development and Manufacturing Organization Product and Solutions
2.1.4 Catalent Pharmaceutical Contract Development and Manufacturing Organization Revenue, Gross Margin and Market Share (2018-2023)
2.1.5 Catalent Recent Developments and Future Plans
2.2 Recipharm
2.2.1 Recipharm Details
2.2.2 Recipharm Major Business
2.2.3 Recipharm Pharmaceutical Contract Development and Manufacturing Organization Product and Solutions
2.2.4 Recipharm Pharmaceutical Contract Development and Manufacturing Organization Revenue, Gross Margin and Market Share (2018-2023)
2.2.5 Recipharm Recent Developments and Future Plans
2.3 Jubilant Life Sciences
2.3.1 Jubilant Life Sciences Details
2.3.2 Jubilant Life Sciences Major Business
2.3.3 Jubilant Life Sciences Pharmaceutical Contract Development and Manufacturing Organization Product and Solutions
2.3.4 Jubilant Life Sciences Pharmaceutical Contract Development and Manufacturing Organization Revenue, Gross Margin and Market Share (2018-2023)
2.3.5 Jubilant Life Sciences Recent Developments and Future Plans
2.4 Patheon Inc.
2.4.1 Patheon Inc. Details
2.4.2 Patheon Inc. Major Business
2.4.3 Patheon Inc. Pharmaceutical Contract Development and Manufacturing Organization Product and Solutions
2.4.4 Patheon Inc. Pharmaceutical Contract Development and Manufacturing Organization Revenue, Gross Margin and Market Share (2018-2023)
2.4.5 Patheon Inc. Recent Developments and Future Plans
2.5 Boehringer Ingelheim
2.5.1 Boehringer Ingelheim Details
2.5.2 Boehringer Ingelheim Major Business
2.5.3 Boehringer Ingelheim Pharmaceutical Contract Development and Manufacturing Organization Product and Solutions
2.5.4 Boehringer Ingelheim Pharmaceutical Contract Development and Manufacturing Organization Revenue, Gross Margin and Market Share (2018-2023)
2.5.5 Boehringer Ingelheim Recent Developments and Future Plans
2.6 Pfizer Centreone
2.6.1 Pfizer Centreone Details
2.6.2 Pfizer Centreone Major Business
2.6.3 Pfizer Centreone Pharmaceutical Contract Development and Manufacturing Organization Product and Solutions
2.6.4 Pfizer Centreone Pharmaceutical Contract Development and Manufacturing Organization Revenue, Gross Margin and Market Share (2018-2023)
2.6.5 Pfizer Centreone Recent Developments and Future Plans
2.7 Aenova Group
2.7.1 Aenova Group Details
2.7.2 Aenova Group Major Business
2.7.3 Aenova Group Pharmaceutical Contract Development and Manufacturing Organization Product and Solutions
2.7.4 Aenova Group Pharmaceutical Contract Development and Manufacturing Organization Revenue, Gross Margin and Market Share (2018-2023)
2.7.5 Aenova Group Recent Developments and Future Plans
2.8 Famar
2.8.1 Famar Details
2.8.2 Famar Major Business
2.8.3 Famar Pharmaceutical Contract Development and Manufacturing Organization Product and Solutions
2.8.4 Famar Pharmaceutical Contract Development and Manufacturing Organization Revenue, Gross Margin and Market Share (2018-2023)
2.8.5 Famar Recent Developments and Future Plans
2.9 Baxter Pharmaceutical Solutions
2.9.1 Baxter Pharmaceutical Solutions Details
2.9.2 Baxter Pharmaceutical Solutions Major Business
2.9.3 Baxter Pharmaceutical Solutions Pharmaceutical Contract Development and Manufacturing Organization Product and Solutions
2.9.4 Baxter Pharmaceutical Solutions Pharmaceutical Contract Development and Manufacturing Organization Revenue, Gross Margin and Market Share (2018-2023)
2.9.5 Baxter Pharmaceutical Solutions Recent Developments and Future Plans
2.10 Lonza Group
2.10.1 Lonza Group Details
2.10.2 Lonza Group Major Business
2.10.3 Lonza Group Pharmaceutical Contract Development and Manufacturing Organization Product and Solutions
2.10.4 Lonza Group Pharmaceutical Contract Development and Manufacturing Organization Revenue, Gross Margin and Market Share (2018-2023)
2.10.5 Lonza Group Recent Developments and Future Plans
2.11 Tesa Labtec
2.11.1 Tesa Labtec Details
2.11.2 Tesa Labtec Major Business
2.11.3 Tesa Labtec Pharmaceutical Contract Development and Manufacturing Organization Product and Solutions
2.11.4 Tesa Labtec Pharmaceutical Contract Development and Manufacturing Organization Revenue, Gross Margin and Market Share (2018-2023)
2.11.5 Tesa Labtec Recent Developments and Future Plans
2.12 Tapemark
2.12.1 Tapemark Details
2.12.2 Tapemark Major Business
2.12.3 Tapemark Pharmaceutical Contract Development and Manufacturing Organization Product and Solutions
2.12.4 Tapemark Pharmaceutical Contract Development and Manufacturing Organization Revenue, Gross Margin and Market Share (2018-2023)
2.12.5 Tapemark Recent Developments and Future Plans
2.13 ARX LLC
2.13.1 ARX LLC Details
2.13.2 ARX LLC Major Business
2.13.3 ARX LLC Pharmaceutical Contract Development and Manufacturing Organization Product and Solutions
2.13.4 ARX LLC Pharmaceutical Contract Development and Manufacturing Organization Revenue, Gross Margin and Market Share (2018-2023)
2.13.5 ARX LLC Recent Developments and Future Plans
2.14 Cambrex
2.14.1 Cambrex Details
2.14.2 Cambrex Major Business
2.14.3 Cambrex Pharmaceutical Contract Development and Manufacturing Organization Product and Solutions
2.14.4 Cambrex Pharmaceutical Contract Development and Manufacturing Organization Revenue, Gross Margin and Market Share (2018-2023)
2.14.5 Cambrex Recent Developments and Future Plans
2.15 Samsung Biologics
2.15.1 Samsung Biologics Details
2.15.2 Samsung Biologics Major Business
2.15.3 Samsung Biologics Pharmaceutical Contract Development and Manufacturing Organization Product and Solutions
2.15.4 Samsung Biologics Pharmaceutical Contract Development and Manufacturing Organization Revenue, Gross Margin and Market Share (2018-2023)
2.15.5 Samsung Biologics Recent Developments and Future Plans
2.16 Fujifilm Diosynth Biotechnologies
2.16.1 Fujifilm Diosynth Biotechnologies Details
2.16.2 Fujifilm Diosynth Biotechnologies Major Business
2.16.3 Fujifilm Diosynth Biotechnologies Pharmaceutical Contract Development and Manufacturing Organization Product and Solutions
2.16.4 Fujifilm Diosynth Biotechnologies Pharmaceutical Contract Development and Manufacturing Organization Revenue, Gross Margin and Market Share (2018-2023)
2.16.5 Fujifilm Diosynth Biotechnologies Recent Developments and Future Plans
2.17 WuXi Biologics
2.17.1 WuXi Biologics Details
2.17.2 WuXi Biologics Major Business
2.17.3 WuXi Biologics Pharmaceutical Contract Development and Manufacturing Organization Product and Solutions
2.17.4 WuXi Biologics Pharmaceutical Contract Development and Manufacturing Organization Revenue, Gross Margin and Market Share (2018-2023)
2.17.5 WuXi Biologics Recent Developments and Future Plans
2.18 Center for Breakthrough Medicines (CBM)
2.18.1 Center for Breakthrough Medicines (CBM) Details
2.18.2 Center for Breakthrough Medicines (CBM) Major Business
2.18.3 Center for Breakthrough Medicines (CBM) Pharmaceutical Contract Development and Manufacturing Organization Product and Solutions
2.18.4 Center for Breakthrough Medicines (CBM) Pharmaceutical Contract Development and Manufacturing Organization Revenue, Gross Margin and Market Share (2018-2023)
2.18.5 Center for Breakthrough Medicines (CBM) Recent Developments and Future Plans
2.19 Siegfried AG
2.19.1 Siegfried AG Details
2.19.2 Siegfried AG Major Business
2.19.3 Siegfried AG Pharmaceutical Contract Development and Manufacturing Organization Product and Solutions
2.19.4 Siegfried AG Pharmaceutical Contract Development and Manufacturing Organization Revenue, Gross Margin and Market Share (2018-2023)
2.19.5 Siegfried AG Recent Developments and Future Plans
3 Market Competition, by Players
3.1 Global Pharmaceutical Contract Development and Manufacturing Organization Revenue and Share by Players (2018-2023)
3.2 Market Share Analysis (2022)
3.2.1 Market Share of Pharmaceutical Contract Development and Manufacturing Organization by Company Revenue
3.2.2 Top 3 Pharmaceutical Contract Development and Manufacturing Organization Players Market Share in 2022
3.2.3 Top 6 Pharmaceutical Contract Development and Manufacturing Organization Players Market Share in 2022
3.3 Pharmaceutical Contract Development and Manufacturing Organization Market: Overall Company Footprint Analysis
3.3.1 Pharmaceutical Contract Development and Manufacturing Organization Market: Region Footprint
3.3.2 Pharmaceutical Contract Development and Manufacturing Organization Market: Company Product Type Footprint
3.3.3 Pharmaceutical Contract Development and Manufacturing Organization Market: Company Product Application Footprint
3.4 New Market Entrants and Barriers to Market Entry
3.5 Mergers, Acquisition, Agreements, and Collaborations
4 Market Size Segment by Type
4.1 Global Pharmaceutical Contract Development and Manufacturing Organization Consumption Value and Market Share by Type (2018-2023)
4.2 Global Pharmaceutical Contract Development and Manufacturing Organization Market Forecast by Type (2024-2029)
5 Market Size Segment by Application
5.1 Global Pharmaceutical Contract Development and Manufacturing Organization Consumption Value Market Share by Application (2018-2023)
5.2 Global Pharmaceutical Contract Development and Manufacturing Organization Market Forecast by Application (2024-2029)
6 North America
6.1 North America Pharmaceutical Contract Development and Manufacturing Organization Consumption Value by Type (2018-2029)
6.2 North America Pharmaceutical Contract Development and Manufacturing Organization Consumption Value by Application (2018-2029)
6.3 North America Pharmaceutical Contract Development and Manufacturing Organization Market Size by Country
6.3.1 North America Pharmaceutical Contract Development and Manufacturing Organization Consumption Value by Country (2018-2029)
6.3.2 United States Pharmaceutical Contract Development and Manufacturing Organization Market Size and Forecast (2018-2029)
6.3.3 Canada Pharmaceutical Contract Development and Manufacturing Organization Market Size and Forecast (2018-2029)
6.3.4 Mexico Pharmaceutical Contract Development and Manufacturing Organization Market Size and Forecast (2018-2029)
7 Europe
7.1 Europe Pharmaceutical Contract Development and Manufacturing Organization Consumption Value by Type (2018-2029)
7.2 Europe Pharmaceutical Contract Development and Manufacturing Organization Consumption Value by Application (2018-2029)
7.3 Europe Pharmaceutical Contract Development and Manufacturing Organization Market Size by Country
7.3.1 Europe Pharmaceutical Contract Development and Manufacturing Organization Consumption Value by Country (2018-2029)
7.3.2 Germany Pharmaceutical Contract Development and Manufacturing Organization Market Size and Forecast (2018-2029)
7.3.3 France Pharmaceutical Contract Development and Manufacturing Organization Market Size and Forecast (2018-2029)
7.3.4 United Kingdom Pharmaceutical Contract Development and Manufacturing Organization Market Size and Forecast (2018-2029)
7.3.5 Russia Pharmaceutical Contract Development and Manufacturing Organization Market Size and Forecast (2018-2029)
7.3.6 Italy Pharmaceutical Contract Development and Manufacturing Organization Market Size and Forecast (2018-2029)
8 Asia-Pacific
8.1 Asia-Pacific Pharmaceutical Contract Development and Manufacturing Organization Consumption Value by Type (2018-2029)
8.2 Asia-Pacific Pharmaceutical Contract Development and Manufacturing Organization Consumption Value by Application (2018-2029)
8.3 Asia-Pacific Pharmaceutical Contract Development and Manufacturing Organization Market Size by Region
8.3.1 Asia-Pacific Pharmaceutical Contract Development and Manufacturing Organization Consumption Value by Region (2018-2029)
8.3.2 China Pharmaceutical Contract Development and Manufacturing Organization Market Size and Forecast (2018-2029)
8.3.3 Japan Pharmaceutical Contract Development and Manufacturing Organization Market Size and Forecast (2018-2029)
8.3.4 South Korea Pharmaceutical Contract Development and Manufacturing Organization Market Size and Forecast (2018-2029)
8.3.5 India Pharmaceutical Contract Development and Manufacturing Organization Market Size and Forecast (2018-2029)
8.3.6 Southeast Asia Pharmaceutical Contract Development and Manufacturing Organization Market Size and Forecast (2018-2029)
8.3.7 Australia Pharmaceutical Contract Development and Manufacturing Organization Market Size and Forecast (2018-2029)
9 South America
9.1 South America Pharmaceutical Contract Development and Manufacturing Organization Consumption Value by Type (2018-2029)
9.2 South America Pharmaceutical Contract Development and Manufacturing Organization Consumption Value by Application (2018-2029)
9.3 South America Pharmaceutical Contract Development and Manufacturing Organization Market Size by Country
9.3.1 South America Pharmaceutical Contract Development and Manufacturing Organization Consumption Value by Country (2018-2029)
9.3.2 Brazil Pharmaceutical Contract Development and Manufacturing Organization Market Size and Forecast (2018-2029)
9.3.3 Argentina Pharmaceutical Contract Development and Manufacturing Organization Market Size and Forecast (2018-2029)
10 Middle East & Africa
10.1 Middle East & Africa Pharmaceutical Contract Development and Manufacturing Organization Consumption Value by Type (2018-2029)
10.2 Middle East & Africa Pharmaceutical Contract Development and Manufacturing Organization Consumption Value by Application (2018-2029)
10.3 Middle East & Africa Pharmaceutical Contract Development and Manufacturing Organization Market Size by Country
10.3.1 Middle East & Africa Pharmaceutical Contract Development and Manufacturing Organization Consumption Value by Country (2018-2029)
10.3.2 Turkey Pharmaceutical Contract Development and Manufacturing Organization Market Size and Forecast (2018-2029)
10.3.3 Saudi Arabia Pharmaceutical Contract Development and Manufacturing Organization Market Size and Forecast (2018-2029)
10.3.4 UAE Pharmaceutical Contract Development and Manufacturing Organization Market Size and Forecast (2018-2029)
11 Market Dynamics
11.1 Pharmaceutical Contract Development and Manufacturing Organization Market Drivers
11.2 Pharmaceutical Contract Development and Manufacturing Organization Market Restraints
11.3 Pharmaceutical Contract Development and Manufacturing Organization Trends Analysis
11.4 Porters Five Forces Analysis
11.4.1 Threat of New Entrants
11.4.2 Bargaining Power of Suppliers
11.4.3 Bargaining Power of Buyers
11.4.4 Threat of Substitutes
11.4.5 Competitive Rivalry
11.5 Influence of COVID-19 and Russia-Ukraine War
11.5.1 Influence of COVID-19
11.5.2 Influence of Russia-Ukraine War
12 Industry Chain Analysis
12.1 Pharmaceutical Contract Development and Manufacturing Organization Industry Chain
12.2 Pharmaceutical Contract Development and Manufacturing Organization Upstream Analysis
12.3 Pharmaceutical Contract Development and Manufacturing Organization Midstream Analysis
12.4 Pharmaceutical Contract Development and Manufacturing Organization Downstream Analysis
13 Research Findings and Conclusion
14 Appendix
14.1 Methodology
14.2 Research Process and Data Source
14.3 Disclaimer
List of Tables
Table 1. Global Pharmaceutical Contract Development and Manufacturing Organization Consumption Value by Type, (USD Million), 2018 & 2022 & 2029
Table 2. Global Pharmaceutical Contract Development and Manufacturing Organization Consumption Value by Application, (USD Million), 2018 & 2022 & 2029
Table 3. Global Pharmaceutical Contract Development and Manufacturing Organization Consumption Value by Region (2018-2023) & (USD Million)
Table 4. Global Pharmaceutical Contract Development and Manufacturing Organization Consumption Value by Region (2024-2029) & (USD Million)
Table 5. Catalent Company Information, Head Office, and Major Competitors
Table 6. Catalent Major Business
Table 7. Catalent Pharmaceutical Contract Development and Manufacturing Organization Product and Solutions
Table 8. Catalent Pharmaceutical Contract Development and Manufacturing Organization Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 9. Catalent Recent Developments and Future Plans
Table 10. Recipharm Company Information, Head Office, and Major Competitors
Table 11. Recipharm Major Business
Table 12. Recipharm Pharmaceutical Contract Development and Manufacturing Organization Product and Solutions
Table 13. Recipharm Pharmaceutical Contract Development and Manufacturing Organization Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 14. Recipharm Recent Developments and Future Plans
Table 15. Jubilant Life Sciences Company Information, Head Office, and Major Competitors
Table 16. Jubilant Life Sciences Major Business
Table 17. Jubilant Life Sciences Pharmaceutical Contract Development and Manufacturing Organization Product and Solutions
Table 18. Jubilant Life Sciences Pharmaceutical Contract Development and Manufacturing Organization Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 19. Jubilant Life Sciences Recent Developments and Future Plans
Table 20. Patheon Inc. Company Information, Head Office, and Major Competitors
Table 21. Patheon Inc. Major Business
Table 22. Patheon Inc. Pharmaceutical Contract Development and Manufacturing Organization Product and Solutions
Table 23. Patheon Inc. Pharmaceutical Contract Development and Manufacturing Organization Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 24. Patheon Inc. Recent Developments and Future Plans
Table 25. Boehringer Ingelheim Company Information, Head Office, and Major Competitors
Table 26. Boehringer Ingelheim Major Business
Table 27. Boehringer Ingelheim Pharmaceutical Contract Development and Manufacturing Organization Product and Solutions
Table 28. Boehringer Ingelheim Pharmaceutical Contract Development and Manufacturing Organization Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 29. Boehringer Ingelheim Recent Developments and Future Plans
Table 30. Pfizer Centreone Company Information, Head Office, and Major Competitors
Table 31. Pfizer Centreone Major Business
Table 32. Pfizer Centreone Pharmaceutical Contract Development and Manufacturing Organization Product and Solutions
Table 33. Pfizer Centreone Pharmaceutical Contract Development and Manufacturing Organization Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 34. Pfizer Centreone Recent Developments and Future Plans
Table 35. Aenova Group Company Information, Head Office, and Major Competitors
Table 36. Aenova Group Major Business
Table 37. Aenova Group Pharmaceutical Contract Development and Manufacturing Organization Product and Solutions
Table 38. Aenova Group Pharmaceutical Contract Development and Manufacturing Organization Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 39. Aenova Group Recent Developments and Future Plans
Table 40. Famar Company Information, Head Office, and Major Competitors
Table 41. Famar Major Business
Table 42. Famar Pharmaceutical Contract Development and Manufacturing Organization Product and Solutions
Table 43. Famar Pharmaceutical Contract Development and Manufacturing Organization Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 44. Famar Recent Developments and Future Plans
Table 45. Baxter Pharmaceutical Solutions Company Information, Head Office, and Major Competitors
Table 46. Baxter Pharmaceutical Solutions Major Business
Table 47. Baxter Pharmaceutical Solutions Pharmaceutical Contract Development and Manufacturing Organization Product and Solutions
Table 48. Baxter Pharmaceutical Solutions Pharmaceutical Contract Development and Manufacturing Organization Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 49. Baxter Pharmaceutical Solutions Recent Developments and Future Plans
Table 50. Lonza Group Company Information, Head Office, and Major Competitors
Table 51. Lonza Group Major Business
Table 52. Lonza Group Pharmaceutical Contract Development and Manufacturing Organization Product and Solutions
Table 53. Lonza Group Pharmaceutical Contract Development and Manufacturing Organization Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 54. Lonza Group Recent Developments and Future Plans
Table 55. Tesa Labtec Company Information, Head Office, and Major Competitors
Table 56. Tesa Labtec Major Business
Table 57. Tesa Labtec Pharmaceutical Contract Development and Manufacturing Organization Product and Solutions
Table 58. Tesa Labtec Pharmaceutical Contract Development and Manufacturing Organization Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 59. Tesa Labtec Recent Developments and Future Plans
Table 60. Tapemark Company Information, Head Office, and Major Competitors
Table 61. Tapemark Major Business
Table 62. Tapemark Pharmaceutical Contract Development and Manufacturing Organization Product and Solutions
Table 63. Tapemark Pharmaceutical Contract Development and Manufacturing Organization Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 64. Tapemark Recent Developments and Future Plans
Table 65. ARX LLC Company Information, Head Office, and Major Competitors
Table 66. ARX LLC Major Business
Table 67. ARX LLC Pharmaceutical Contract Development and Manufacturing Organization Product and Solutions
Table 68. ARX LLC Pharmaceutical Contract Development and Manufacturing Organization Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 69. ARX LLC Recent Developments and Future Plans
Table 70. Cambrex Company Information, Head Office, and Major Competitors
Table 71. Cambrex Major Business
Table 72. Cambrex Pharmaceutical Contract Development and Manufacturing Organization Product and Solutions
Table 73. Cambrex Pharmaceutical Contract Development and Manufacturing Organization Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 74. Cambrex Recent Developments and Future Plans
Table 75. Samsung Biologics Company Information, Head Office, and Major Competitors
Table 76. Samsung Biologics Major Business
Table 77. Samsung Biologics Pharmaceutical Contract Development and Manufacturing Organization Product and Solutions
Table 78. Samsung Biologics Pharmaceutical Contract Development and Manufacturing Organization Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 79. Samsung Biologics Recent Developments and Future Plans
Table 80. Fujifilm Diosynth Biotechnologies Company Information, Head Office, and Major Competitors
Table 81. Fujifilm Diosynth Biotechnologies Major Business
Table 82. Fujifilm Diosynth Biotechnologies Pharmaceutical Contract Development and Manufacturing Organization Product and Solutions
Table 83. Fujifilm Diosynth Biotechnologies Pharmaceutical Contract Development and Manufacturing Organization Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 84. Fujifilm Diosynth Biotechnologies Recent Developments and Future Plans
Table 85. WuXi Biologics Company Information, Head Office, and Major Competitors
Table 86. WuXi Biologics Major Business
Table 87. WuXi Biologics Pharmaceutical Contract Development and Manufacturing Organization Product and Solutions
Table 88. WuXi Biologics Pharmaceutical Contract Development and Manufacturing Organization Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 89. WuXi Biologics Recent Developments and Future Plans
Table 90. Center for Breakthrough Medicines (CBM) Company Information, Head Office, and Major Competitors
Table 91. Center for Breakthrough Medicines (CBM) Major Business
Table 92. Center for Breakthrough Medicines (CBM) Pharmaceutical Contract Development and Manufacturing Organization Product and Solutions
Table 93. Center for Breakthrough Medicines (CBM) Pharmaceutical Contract Development and Manufacturing Organization Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 94. Center for Breakthrough Medicines (CBM) Recent Developments and Future Plans
Table 95. Siegfried AG Company Information, Head Office, and Major Competitors
Table 96. Siegfried AG Major Business
Table 97. Siegfried AG Pharmaceutical Contract Development and Manufacturing Organization Product and Solutions
Table 98. Siegfried AG Pharmaceutical Contract Development and Manufacturing Organization Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 99. Siegfried AG Recent Developments and Future Plans
Table 100. Global Pharmaceutical Contract Development and Manufacturing Organization Revenue (USD Million) by Players (2018-2023)
Table 101. Global Pharmaceutical Contract Development and Manufacturing Organization Revenue Share by Players (2018-2023)
Table 102. Breakdown of Pharmaceutical Contract Development and Manufacturing Organization by Company Type (Tier 1, Tier 2, and Tier 3)
Table 103. Market Position of Players in Pharmaceutical Contract Development and Manufacturing Organization, (Tier 1, Tier 2, and Tier 3), Based on Revenue in 2022
Table 104. Head Office of Key Pharmaceutical Contract Development and Manufacturing Organization Players
Table 105. Pharmaceutical Contract Development and Manufacturing Organization Market: Company Product Type Footprint
Table 106. Pharmaceutical Contract Development and Manufacturing Organization Market: Company Product Application Footprint
Table 107. Pharmaceutical Contract Development and Manufacturing Organization New Market Entrants and Barriers to Market Entry
Table 108. Pharmaceutical Contract Development and Manufacturing Organization Mergers, Acquisition, Agreements, and Collaborations
Table 109. Global Pharmaceutical Contract Development and Manufacturing Organization Consumption Value (USD Million) by Type (2018-2023)
Table 110. Global Pharmaceutical Contract Development and Manufacturing Organization Consumption Value Share by Type (2018-2023)
Table 111. Global Pharmaceutical Contract Development and Manufacturing Organization Consumption Value Forecast by Type (2024-2029)
Table 112. Global Pharmaceutical Contract Development and Manufacturing Organization Consumption Value by Application (2018-2023)
Table 113. Global Pharmaceutical Contract Development and Manufacturing Organization Consumption Value Forecast by Application (2024-2029)
Table 114. North America Pharmaceutical Contract Development and Manufacturing Organization Consumption Value by Type (2018-2023) & (USD Million)
Table 115. North America Pharmaceutical Contract Development and Manufacturing Organization Consumption Value by Type (2024-2029) & (USD Million)
Table 116. North America Pharmaceutical Contract Development and Manufacturing Organization Consumption Value by Application (2018-2023) & (USD Million)
Table 117. North America Pharmaceutical Contract Development and Manufacturing Organization Consumption Value by Application (2024-2029) & (USD Million)
Table 118. North America Pharmaceutical Contract Development and Manufacturing Organization Consumption Value by Country (2018-2023) & (USD Million)
Table 119. North America Pharmaceutical Contract Development and Manufacturing Organization Consumption Value by Country (2024-2029) & (USD Million)
Table 120. Europe Pharmaceutical Contract Development and Manufacturing Organization Consumption Value by Type (2018-2023) & (USD Million)
Table 121. Europe Pharmaceutical Contract Development and Manufacturing Organization Consumption Value by Type (2024-2029) & (USD Million)
Table 122. Europe Pharmaceutical Contract Development and Manufacturing Organization Consumption Value by Application (2018-2023) & (USD Million)
Table 123. Europe Pharmaceutical Contract Development and Manufacturing Organization Consumption Value by Application (2024-2029) & (USD Million)
Table 124. Europe Pharmaceutical Contract Development and Manufacturing Organization Consumption Value by Country (2018-2023) & (USD Million)
Table 125. Europe Pharmaceutical Contract Development and Manufacturing Organization Consumption Value by Country (2024-2029) & (USD Million)
Table 126. Asia-Pacific Pharmaceutical Contract Development and Manufacturing Organization Consumption Value by Type (2018-2023) & (USD Million)
Table 127. Asia-Pacific Pharmaceutical Contract Development and Manufacturing Organization Consumption Value by Type (2024-2029) & (USD Million)
Table 128. Asia-Pacific Pharmaceutical Contract Development and Manufacturing Organization Consumption Value by Application (2018-2023) & (USD Million)
Table 129. Asia-Pacific Pharmaceutical Contract Development and Manufacturing Organization Consumption Value by Application (2024-2029) & (USD Million)
Table 130. Asia-Pacific Pharmaceutical Contract Development and Manufacturing Organization Consumption Value by Region (2018-2023) & (USD Million)
Table 131. Asia-Pacific Pharmaceutical Contract Development and Manufacturing Organization Consumption Value by Region (2024-2029) & (USD Million)
Table 132. South America Pharmaceutical Contract Development and Manufacturing Organization Consumption Value by Type (2018-2023) & (USD Million)
Table 133. South America Pharmaceutical Contract Development and Manufacturing Organization Consumption Value by Type (2024-2029) & (USD Million)
Table 134. South America Pharmaceutical Contract Development and Manufacturing Organization Consumption Value by Application (2018-2023) & (USD Million)
Table 135. South America Pharmaceutical Contract Development and Manufacturing Organization Consumption Value by Application (2024-2029) & (USD Million)
Table 136. South America Pharmaceutical Contract Development and Manufacturing Organization Consumption Value by Country (2018-2023) & (USD Million)
Table 137. South America Pharmaceutical Contract Development and Manufacturing Organization Consumption Value by Country (2024-2029) & (USD Million)
Table 138. Middle East & Africa Pharmaceutical Contract Development and Manufacturing Organization Consumption Value by Type (2018-2023) & (USD Million)
Table 139. Middle East & Africa Pharmaceutical Contract Development and Manufacturing Organization Consumption Value by Type (2024-2029) & (USD Million)
Table 140. Middle East & Africa Pharmaceutical Contract Development and Manufacturing Organization Consumption Value by Application (2018-2023) & (USD Million)
Table 141. Middle East & Africa Pharmaceutical Contract Development and Manufacturing Organization Consumption Value by Application (2024-2029) & (USD Million)
Table 142. Middle East & Africa Pharmaceutical Contract Development and Manufacturing Organization Consumption Value by Country (2018-2023) & (USD Million)
Table 143. Middle East & Africa Pharmaceutical Contract Development and Manufacturing Organization Consumption Value by Country (2024-2029) & (USD Million)
Table 144. Pharmaceutical Contract Development and Manufacturing Organization Raw Material
Table 145. Key Suppliers of Pharmaceutical Contract Development and Manufacturing Organization Raw Materials
List of Figures
Figure 1. Pharmaceutical Contract Development and Manufacturing Organization Picture
Figure 2. Global Pharmaceutical Contract Development and Manufacturing Organization Consumption Value by Type, (USD Million), 2018 & 2022 & 2029
Figure 3. Global Pharmaceutical Contract Development and Manufacturing Organization Consumption Value Market Share by Type in 2022
Figure 4. API Development
Figure 5. Pharmaceutical Manufacturing
Figure 6. Global Pharmaceutical Contract Development and Manufacturing Organization Consumption Value by Type, (USD Million), 2018 & 2022 & 2029
Figure 7. Pharmaceutical Contract Development and Manufacturing Organization Consumption Value Market Share by Application in 2022
Figure 8. Large Enterprise Picture
Figure 9. SME Picture
Figure 10. Global Pharmaceutical Contract Development and Manufacturing Organization Consumption Value, (USD Million): 2018 & 2022 & 2029
Figure 11. Global Pharmaceutical Contract Development and Manufacturing Organization Consumption Value and Forecast (2018-2029) & (USD Million)
Figure 12. Global Market Pharmaceutical Contract Development and Manufacturing Organization Consumption Value (USD Million) Comparison by Region (2018 & 2022 & 2029)
Figure 13. Global Pharmaceutical Contract Development and Manufacturing Organization Consumption Value Market Share by Region (2018-2029)
Figure 14. Global Pharmaceutical Contract Development and Manufacturing Organization Consumption Value Market Share by Region in 2022
Figure 15. North America Pharmaceutical Contract Development and Manufacturing Organization Consumption Value (2018-2029) & (USD Million)
Figure 16. Europe Pharmaceutical Contract Development and Manufacturing Organization Consumption Value (2018-2029) & (USD Million)
Figure 17. Asia-Pacific Pharmaceutical Contract Development and Manufacturing Organization Consumption Value (2018-2029) & (USD Million)
Figure 18. South America Pharmaceutical Contract Development and Manufacturing Organization Consumption Value (2018-2029) & (USD Million)
Figure 19. Middle East and Africa Pharmaceutical Contract Development and Manufacturing Organization Consumption Value (2018-2029) & (USD Million)
Figure 20. Global Pharmaceutical Contract Development and Manufacturing Organization Revenue Share by Players in 2022
Figure 21. Pharmaceutical Contract Development and Manufacturing Organization Market Share by Company Type (Tier 1, Tier 2 and Tier 3) in 2022
Figure 22. Global Top 3 Players Pharmaceutical Contract Development and Manufacturing Organization Market Share in 2022
Figure 23. Global Top 6 Players Pharmaceutical Contract Development and Manufacturing Organization Market Share in 2022
Figure 24. Global Pharmaceutical Contract Development and Manufacturing Organization Consumption Value Share by Type (2018-2023)
Figure 25. Global Pharmaceutical Contract Development and Manufacturing Organization Market Share Forecast by Type (2024-2029)
Figure 26. Global Pharmaceutical Contract Development and Manufacturing Organization Consumption Value Share by Application (2018-2023)
Figure 27. Global Pharmaceutical Contract Development and Manufacturing Organization Market Share Forecast by Application (2024-2029)
Figure 28. North America Pharmaceutical Contract Development and Manufacturing Organization Consumption Value Market Share by Type (2018-2029)
Figure 29. North America Pharmaceutical Contract Development and Manufacturing Organization Consumption Value Market Share by Application (2018-2029)
Figure 30. North America Pharmaceutical Contract Development and Manufacturing Organization Consumption Value Market Share by Country (2018-2029)
Figure 31. United States Pharmaceutical Contract Development and Manufacturing Organization Consumption Value (2018-2029) & (USD Million)
Figure 32. Canada Pharmaceutical Contract Development and Manufacturing Organization Consumption Value (2018-2029) & (USD Million)
Figure 33. Mexico Pharmaceutical Contract Development and Manufacturing Organization Consumption Value (2018-2029) & (USD Million)
Figure 34. Europe Pharmaceutical Contract Development and Manufacturing Organization Consumption Value Market Share by Type (2018-2029)
Figure 35. Europe Pharmaceutical Contract Development and Manufacturing Organization Consumption Value Market Share by Application (2018-2029)
Figure 36. Europe Pharmaceutical Contract Development and Manufacturing Organization Consumption Value Market Share by Country (2018-2029)
Figure 37. Germany Pharmaceutical Contract Development and Manufacturing Organization Consumption Value (2018-2029) & (USD Million)
Figure 38. France Pharmaceutical Contract Development and Manufacturing Organization Consumption Value (2018-2029) & (USD Million)
Figure 39. United Kingdom Pharmaceutical Contract Development and Manufacturing Organization Consumption Value (2018-2029) & (USD Million)
Figure 40. Russia Pharmaceutical Contract Development and Manufacturing Organization Consumption Value (2018-2029) & (USD Million)
Figure 41. Italy Pharmaceutical Contract Development and Manufacturing Organization Consumption Value (2018-2029) & (USD Million)
Figure 42. Asia-Pacific Pharmaceutical Contract Development and Manufacturing Organization Consumption Value Market Share by Type (2018-2029)
Figure 43. Asia-Pacific Pharmaceutical Contract Development and Manufacturing Organization Consumption Value Market Share by Application (2018-2029)
Figure 44. Asia-Pacific Pharmaceutical Contract Development and Manufacturing Organization Consumption Value Market Share by Region (2018-2029)
Figure 45. China Pharmaceutical Contract Development and Manufacturing Organization Consumption Value (2018-2029) & (USD Million)
Figure 46. Japan Pharmaceutical Contract Development and Manufacturing Organization Consumption Value (2018-2029) & (USD Million)
Figure 47. South Korea Pharmaceutical Contract Development and Manufacturing Organization Consumption Value (2018-2029) & (USD Million)
Figure 48. India Pharmaceutical Contract Development and Manufacturing Organization Consumption Value (2018-2029) & (USD Million)
Figure 49. Southeast Asia Pharmaceutical Contract Development and Manufacturing Organization Consumption Value (2018-2029) & (USD Million)
Figure 50. Australia Pharmaceutical Contract Development and Manufacturing Organization Consumption Value (2018-2029) & (USD Million)
Figure 51. South America Pharmaceutical Contract Development and Manufacturing Organization Consumption Value Market Share by Type (2018-2029)
Figure 52. South America Pharmaceutical Contract Development and Manufacturing Organization Consumption Value Market Share by Application (2018-2029)
Figure 53. South America Pharmaceutical Contract Development and Manufacturing Organization Consumption Value Market Share by Country (2018-2029)
Figure 54. Brazil Pharmaceutical Contract Development and Manufacturing Organization Consumption Value (2018-2029) & (USD Million)
Figure 55. Argentina Pharmaceutical Contract Development and Manufacturing Organization Consumption Value (2018-2029) & (USD Million)
Figure 56. Middle East and Africa Pharmaceutical Contract Development and Manufacturing Organization Consumption Value Market Share by Type (2018-2029)
Figure 57. Middle East and Africa Pharmaceutical Contract Development and Manufacturing Organization Consumption Value Market Share by Application (2018-2029)
Figure 58. Middle East and Africa Pharmaceutical Contract Development and Manufacturing Organization Consumption Value Market Share by Country (2018-2029)
Figure 59. Turkey Pharmaceutical Contract Development and Manufacturing Organization Consumption Value (2018-2029) & (USD Million)
Figure 60. Saudi Arabia Pharmaceutical Contract Development and Manufacturing Organization Consumption Value (2018-2029) & (USD Million)
Figure 61. UAE Pharmaceutical Contract Development and Manufacturing Organization Consumption Value (2018-2029) & (USD Million)
Figure 62. Pharmaceutical Contract Development and Manufacturing Organization Market Drivers
Figure 63. Pharmaceutical Contract Development and Manufacturing Organization Market Restraints
Figure 64. Pharmaceutical Contract Development and Manufacturing Organization Market Trends
Figure 65. Porters Five Forces Analysis
Figure 66. Manufacturing Cost Structure Analysis of Pharmaceutical Contract Development and Manufacturing Organization in 2022
Figure 67. Manufacturing Process Analysis of Pharmaceutical Contract Development and Manufacturing Organization
Figure 68. Pharmaceutical Contract Development and Manufacturing Organization Industrial Chain
Figure 69. Methodology
Figure 70. Research Process and Data Source
Please feel free to write an email to us or to use our electronic ticketing system.
